Breaking News Instant updates and real-time market news.

INSM

Insmed

$17.13

-0.26 (-1.50%)

16:30
05/19/17
05/19
16:30
05/19/17
16:30

Insmed files common stock shelf

  • 19

    May

  • 30

    May

  • 31

    May

INSM Insmed
$17.13

-0.26 (-1.50%)

05/04/17
LEER
05/04/17
NO CHANGE
Target $27
LEER
Outperform
Insmed price target raised to $27 from $21 at Leerink
Leerink analyst Joseph Schwartz raised his price target for Insmed to $27 from $21 to reflect Q1 net income/EPS and management's current estimates for the refractory NTM opportunity. The analyst notes that the upcoming Phase 3 data from the CONVERT study investigating Arikayce in patients with nontuberculous mycobacterium lung infections remains a key binary catalyst for investors. Additionally, he sees a positive outcome surrounding INS-1007 bolstering Insmed's position as a leading biotechnology company in the rare pulmonology disease space. The analyst reiterates an Outperform rating on the shares.
05/01/17
STFL
05/01/17
NO CHANGE
STFL
Insmed should be bought ahead of data, says Stifel
After speaking with three key opinion leaders familiar with Insmed's Arikayce drug, Stifel analyst Adam Walsh says all three experts think that the drug can meet its primary Phase III endpoint. The experts think that the drug's response rate could be about 30% higher than the standard of care. The analyst believes that this implies that the experts expect the Phase 3 results to be strong, and he recommends buying the stock ahead of the results which are due out in September. The analyst raised his price target on the stock to $27 from $23 and keeps a Buy rating on the shares.
06/09/16
LEER
06/09/16
NO CHANGE
Target $21
LEER
Outperform
Insmed withdrawal in Europe a minor setback, says Leerink
Leerink analyst Joseph Schwartz says Insmed decided to withdraw its Marketing Authorization Application from the European Medicines Agency for its Arikayce in treating patients with nontuberculous mycobacterium infections. The analyst sees this setback as minor as Phase 3 CONVERT study continues to enroll patients allowing the company to return with "better, more convincing" clinical data at a later date. Schwartz reiterates an Outperform rating on the stock but lowered his price target on the shares to $21 from $23.
06/09/16
PIPR
06/09/16
NO CHANGE
Target $24
PIPR
Overweight
Insmed withdrawal in Europe does little to change outlook, says Piper Jaffray
Piper Jaffray analyst Joshua Schimmer says Insmed's decision to withdraw its Marketing Authorization Application from the European Medicines Agency for Arikayce for the treatment of nontuberculous mycobacteria lung disease does little to change the company's outlook. Like the FDA, the European regulators want to see the results of the full Phase 3 Convert study, which will report in 2017, Schimmer tells investors in a research note. Success in the Phase 3 trial likely would have been needed to stay on the market anyways, the analyst contends. He keeps an Overweight rating on Insmed with a $24 price target.

TODAY'S FREE FLY STORIES

AZO

AutoZone

$659.49

-14.16 (-2.10%)

, MOMO

Momo

$42.83

-0.75 (-1.72%)

20:25
05/22/17
05/22
20:25
05/22/17
20:25
Earnings
Notable companies reporting before tomorrow's open »

Notable companies…

AZO

AutoZone

$659.49

-14.16 (-2.10%)

MOMO

Momo

$42.83

-0.75 (-1.72%)

TTWO

Take-Two

$69.04

1.46 (2.16%)

TOL

Toll Brothers

$38.03

0.19 (0.50%)

CBRL

Cracker Barrel

$161.41

2.41 (1.52%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

  • 23

    May

  • 23

    May

  • 23

    May

  • 23

    May

  • 25

    May

  • 29

    Jun

TWX

Time Warner

$97.90

0.27 (0.28%)

, DIS

Disney

$107.63

0.11 (0.10%)

20:07
05/22/17
05/22
20:07
05/22/17
20:07
Periodicals
Zack Snyder steps away from 'Justice League,' Hollywood Reporter says »

Zack Snyder, director of…

TWX

Time Warner

$97.90

0.27 (0.28%)

DIS

Disney

$107.63

0.11 (0.10%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Jun

OMN

Omnova Solutions

$8.90

0.15 (1.71%)

19:54
05/22/17
05/22
19:54
05/22/17
19:54
Conference/Events
Omnova Solutions management to meet with Jefferies »

Meeting to be held in the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    May

19:52
05/22/17
05/22
19:52
05/22/17
19:52
General news
Breaking General news story  »

U.K. police says…

UHAL

Amerco

$384.37

5.63 (1.49%)

19:40
05/22/17
05/22
19:40
05/22/17
19:40
Hot Stocks
U-Haul acquires portable storage containers of Door To Door »

Amerco's U-Haul…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    May

AAPL

Apple

$153.99

0.93 (0.61%)

19:34
05/22/17
05/22
19:34
05/22/17
19:34
Periodicals
Apple launches new Android 'switching' site, ads, AppleInsider says »

Apple has launched an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Jun

AMZN

Amazon.com

$970.67

10.83 (1.13%)

19:34
05/22/17
05/22
19:34
05/22/17
19:34
Periodicals
Amazon plans to offer live TV channels in Europe, FT reports »

Amazon plans to offer…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

TWTR

Twitter

$18.43

0.08 (0.44%)

19:30
05/22/17
05/22
19:30
05/22/17
19:30
Hot Stocks
Twitter hires Todd Swidler as global head of live business »

Twitter COO and CFO…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    May

  • 24

    May

TKPYY

Takeda Pharmaceutical Co. Ltd.

$25.87

0.025 (0.10%)

19:29
05/22/17
05/22
19:29
05/22/17
19:29
Conference/Events
Takeda Pharmaceutical Co. Ltd. management to meet with JPMorgan »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    May

GE

General Electric

$28.18

0.13 (0.46%)

19:27
05/22/17
05/22
19:27
05/22/17
19:27
Periodicals
EU examines potential misleading information in GE merger review, Bloomberg says »

The European Commission…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    May

  • 31

    May

  • 22

    Jun

  • 02

    Oct

GOOG

Alphabet

$941.86

7.85 (0.84%)

, GOOGL

Alphabet Class A

$964.07

9.42 (0.99%)

19:20
05/22/17
05/22
19:20
05/22/17
19:20
Periodicals
Alphabet's Nest working on 4K home security camera, AndroidPolice says »

Alphabet's Nest is…

GOOG

Alphabet

$941.86

7.85 (0.84%)

GOOGL

Alphabet Class A

$964.07

9.42 (0.99%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    May

  • 22

    May

  • 24

    May

CRM

Salesforce

$88.94

1.54 (1.76%)

19:19
05/22/17
05/22
19:19
05/22/17
19:19
Conference/Events
Salesforce management to meet with JPMorgan »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    May

  • 25

    May

  • 08

    Jun

19:15
05/22/17
05/22
19:15
05/22/17
19:15
General news
Breaking General news story  »

Federal Reserve Governor…

GE

General Electric

$28.18

0.13 (0.46%)

19:13
05/22/17
05/22
19:13
05/22/17
19:13
Periodicals
Aerion in talks with GE to power faster jets, Bloomberg reports »

Aerion Corporation is in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    May

  • 31

    May

  • 22

    Jun

  • 02

    Oct

BTU

Peabody Energy

$23.29

-0.01 (-0.04%)

19:13
05/22/17
05/22
19:13
05/22/17
19:13
Conference/Events
Peabody Energy management to meet with JPMorgan »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    May

  • 26

    May

AAPL

Apple

$153.99

0.93 (0.61%)

19:09
05/22/17
05/22
19:09
05/22/17
19:09
Periodicals
Apple Music trial implements small fee in some countries, AppleInsider says »

Apple has started…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Jun

TTWO

Take-Two

$69.04

1.46 (2.16%)

19:09
05/22/17
05/22
19:09
05/22/17
19:09
Recommendations
Take-Two analyst commentary at Piper Jaffray »

Take-Two delay of Red…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

  • 25

    May

BA

Boeing

$183.67

2.91 (1.61%)

, BDRBF

Bombardier

$1.57

0.0197 (1.27%)

19:06
05/22/17
05/22
19:06
05/22/17
19:06
Periodicals
Boeing fight against Bombardier driven by missteps with Airbus, Reuters says »

Boeing's (BA) recent…

BA

Boeing

$183.67

2.91 (1.61%)

BDRBF

Bombardier

$1.57

0.0197 (1.27%)

EADSY

Airbus

$20.38

-0.23 (-1.12%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    May

MTSC

MTS Systems

$53.80

0.45 (0.84%)

19:05
05/22/17
05/22
19:05
05/22/17
19:05
Conference/Events
MTS Systems management to meet with JPMorgan »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    May

  • 01

    Jun

HP

Helmerich & Payne

$59.88

-0.16 (-0.27%)

, HAL

Halliburton

$47.12

-0.66 (-1.38%)

19:04
05/22/17
05/22
19:04
05/22/17
19:04
Downgrade
Helmerich & Payne, Halliburton, ProPetro Holding, U.S. Silica rating change at Goldman Sachs »

Helmerich & Payne…

HP

Helmerich & Payne

$59.88

-0.16 (-0.27%)

HAL

Halliburton

$47.12

-0.66 (-1.38%)

PUMP

ProPetro Holding

$13.59

-0.14 (-1.02%)

SLCA

U.S. Silica

$38.77

-1.65 (-4.08%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

  • 20

    Jun

  • 24

    Jul

INVH

Invitation Homes

$21.67

-0.11 (-0.51%)

19:00
05/22/17
05/22
19:00
05/22/17
19:00
Conference/Events
Invitation Homes management to meet with JPMorgan »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    May

ATW

Atwood Oceanics

$8.73

0.03 (0.34%)

18:59
05/22/17
05/22
18:59
05/22/17
18:59
Upgrade
Atwood Oceanics rating change at Goldman Sachs »

Atwood Oceanics upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TSLA

Tesla

$310.35

-0.48 (-0.15%)

18:56
05/22/17
05/22
18:56
05/22/17
18:56
Periodicals
Tesla confirms less than 100 configurations for Model 3, Electrek says »

Tesla confirmed today…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    May

  • 02

    Oct

EXPGY

Experian

$21.43

0.125 (0.59%)

18:56
05/22/17
05/22
18:56
05/22/17
18:56
Conference/Events
Experian management to meet with JPMorgan »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    May

  • 25

    May

18:55
05/22/17
05/22
18:55
05/22/17
18:55
Conference/Events
Federal Reserve Governor delivers dinner keynote speech »

Federal Reserve Governor…

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.